Records containing: Influenza, Human
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-06-05Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State
-
CLINICAL_TRIALS study record update · 2019-05-15An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe
-
CLINICAL_TRIALS study record update · 2019-02-21A Phase I/II, Randomised, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
-
CLINICAL_TRIALS study record update · 2019-02-11Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
-
CLINICAL_TRIALS study record update · 2019-02-05A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-01-28A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study In Healthy Adult Volunteers In Vietnam To Examine The Safety And Immunogenicity Of A Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced By IVAC
-
CLINICAL_TRIALS study record update · 2019-01-23A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-licensed Quadrivalent Inactivated Comparator Influenza Virus Vaccine (Comparator QIV) in a Pediatric Population 6 Months Through 59 Months of Age
-
CLINICAL_TRIALS study record update · 2019-01-16Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (2018 Southern Hemisphere Season) Produced at Butantan Institute
-
CLINICAL_TRIALS study record update · 2019-01-15A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study to Examine the Safety and Immunogenicity of a Seasonal Trivalent Split, Inactivated Influenza Vaccine Produced by Torlak in Healthy Adult Volunteers in Serbia
-
CLINICAL_TRIALS study record update · 2019-01-10Nudging for Vaccination : Efficacity and Acceptability Among Medical Students
-
CLINICAL_TRIALS study record update · 2019-01-04Open-labeled(Part 1), Single-group(Part 2), Randomized(Part 2), Double-blind(Part 2), Active-controlled(Part 2) Pharse II Clinical Trial to Evaluate Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
-
CLINICAL_TRIALS study record update · 2018-11-19Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.
-
CLINICAL_TRIALS study record update · 2018-09-28A Randomized, Double-blind, Active Comparator, Phase I/Ⅱa Clinical Trial to Assess the Safety and Immunogenicity of the 'IL-YANG Flu Vaccine Quadrivalent Inj.' in Healthy Korean Adult Subjects
-
CLINICAL_TRIALS study record update · 2018-07-26A Phase I/II, Two-Staged, Single-Center, Randomized, Double-Blind, Antibody Titer Study to Assess Immunogenicity and Safety of FluMist® Intranasal Influenza Vaccine Administered With and Without a TLR-3 Agonist, Ampligen®.
-
CLINICAL_TRIALS study record update · 2018-07-12A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
-
CLINICAL_TRIALS study record update · 2018-05-15Comparative Tests of Flu Vaccination Phone Messages
-
CLINICAL_TRIALS study record update · 2018-04-18The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study
-
CLINICAL_TRIALS study record update · 2018-04-04Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
-
CLINICAL_TRIALS study record update · 2018-02-22An Open-label, Multi-centre, Single Arm Study to Evaluate the Safety and Efficacy of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Confirmed Influenza Infection (NAI115215)
-
CLINICAL_TRIALS study record update · 2018-02-06Clinical Performance of the Diassess Influenza A and B Test
-
CLINICAL_TRIALS study record update · 2017-11-30Inactivated Influenza Via Jet Injection
-
CLINICAL_TRIALS study record update · 2017-11-29Evaluation of Correlates of Protective Efficacy of Seasonal Live Attenuated Influenza Vaccine (LAIV) by Utilization of a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus
-
CLINICAL_TRIALS study record update · 2017-11-20A Phase III International, Randomized, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of 300 mg or 600 mg of Intravenous Zanamivir Twice Daily Compared to 75 mg of Oral Oseltamivir Twice Daily in the Treatment of Hospitalized Adults and Adolescents With Influenza
-
CLINICAL_TRIALS study record update · 2017-11-14A Single-centre, Randomised, Observer-blind, Active Comparator-controlled, Superiority Trial of the Immune Response to Six-monthly Versus Annual Standard Dose Inactivated Trivalent Influenza Vaccination in the Elderly
-
CLINICAL_TRIALS study record update · 2017-11-01A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of 'NBP607-QIV(Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine)' in Children Aged 6~35 Months